Merck & Co.’s 1Q18 Earnings: Revenues up 6%
Headquartered in New Jersey, Merck & Co. (MRK) is one of the largest pharmaceutical companies worldwide. Its business is classified into four business segments: Human Pharmaceutical, Animal Health, Healthcare Services, and Alliances. Merck & Co. beat Wall Street analysts’ estimates for earnings per share (or EPS) today but missed analysts’ estimates for revenues. It reported EPS of $1.05 on revenues of $10.0 billion for 1Q18, compared to estimates of EPS of $1.00 on revenues of $10.1 billion.